Skip to content

Baxter International BAX Stock options excluded as their inclusion would be anti-dilutive (in shares)

Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
Solventum logo
SolventumSOLV
Abbott logo
AbbottABT
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
DaVita logo
DaVitaDVA

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's stock options excluded as their inclusion would be anti-dilutive (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's stock options excluded as their inclusion would be anti-dilutive (in shares)?
Baxter International (BAX) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 25M in Q1 2026.
How has Baxter International's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
Baxter International's stock options excluded as their inclusion would be anti-dilutive (in shares) increased by 25.0% year-over-year, from 20M to 25M.
What is the long-term trend for Baxter International's stock options excluded as their inclusion would be anti-dilutive (in shares)?
Over 4 years (2021 to 2025), Baxter International's stock options excluded as their inclusion would be anti-dilutive (in shares) has grown at a 31.6% compound annual growth rate (CAGR), from 28M to 84M.
What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
The number of stock options or other instruments excluded from EPS calculations because they would currently improve, rather than dilute, earnings per share.
How do you interpret stock options excluded as their inclusion would be anti-dilutive (in shares)?
A high number of anti-dilutive securities suggests that the company's current stock price is below the exercise price of many outstanding employee options.
How does stock options excluded as their inclusion would be anti-dilutive (in shares) compare across companies?
Standard disclosure for all publicly traded companies with employee stock compensation plans.